| 货号 |
中文名称 |
英文名词 |
靶点 |
|
VAPD00061 |
Research Grade Namilumab ( 那美芦单抗 ) Biosimilar
|
|
CSF2, GM-CSF |
|
VAPD00060 |
Research Grade Mogamulizumab ( 莫格利组单抗 ) Biosimilar
|
|
CCR4, CMKBR4, CD194 |
|
VAPD00059 |
Research Grade Modotuximab ( 扎妥昔单抗 ) Biosimilar
|
|
EGFR, ERBB, ERBB1, HER1 |
|
VAPD00058 |
Research Grade Mepolizumab ( 美泊珠单抗 ) Biosimilar
|
|
IL5, Interleukin-5 |
|
VAPD00057 |
Research Grade Lirilumab ( 利瑞鲁单抗 ) Biosimilar
|
|
KIR2DL1, CD158A, NKAT1 |
|
VAPD00056 |
Research Grade Ligelizumab Biosimilar
|
|
IGHE, IgE |
|
VAPD00055 |
Research Grade Labetuzumab ( 拉贝珠单抗 ) Biosimilar
|
|
CEACAM5, CEA, CD66e |
|
VAPD00054 |
Research Grade Ixekizumab ( 伊卡组单抗 ) Biosimilar
|
|
IL17A, CTLA8, IL-17A, CTLA-8 |
|
VAPD00053 |
Research Grade Itolizumab ( 伊利组单抗 ) Biosimilar
|
|
Human CD6 |
|
VAPD00052 |
Research Grade Ipilimumab ( 伊匹木单抗 ) Biosimilar
|
|
Human CTLA4 |
